Key Takeaways and Predictions from the 2025 J.P. Morgan Healthcare Conference
San Francisco, January 2025 – The 43rd Annual J.P. Morgan Healthcare Conference convened over 8,000 healthcare leaders and featured presentations from more than 500 companies. From M&A activity to AI-driven transformations, the conference showcased emerging trends and strategic opportunities for healthcare, medtech, and biopharma stakeholders. Conference Highlights Surge in Mergers and Acquisitions (M&A)Johnson & Johnson’s […]
From Prototype to Patient: Innovative GTM Approaches for MedTech/Life Sciences Success
Healthcare, pharma, and medtech companies operate in one of the most complex and rapidly evolving markets. As AI-driven diagnostics, digital therapeutics, and precision medicine advance, the pressure to launch effectively—and remain compliant—has never been greater. A robust Go-to-Market (GTM) strategy can be the deciding factor between stagnation and sustainable growth, particularly given new considerations such […]
